| Product Number |
OAAB17232 |
| Product Page |
www.avivasysbio.com/srms-antibody-n-terminal-region-oaab17232.html |
| Name |
SRMS Antibody - N-terminal region (OAAB17232) |
| Molecular Weight |
54507 Da |
| Isotype |
Ig |
| NCBI Gene Id |
6725 |
| Host |
Rabbit |
| Clonality |
Polyclonal |
| Concentration |
Approximately 0.5mg/ml. Actual concentration varies with each lot. |
| Alias Symbols |
SRM, PTK70, C20orf148, dJ697K14.1 |
| Product Format |
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
| Description of Target |
Purified Rabbit Polyclonal Antibody (Pab) |
| Reconstitution and Storage |
Maintain refrigerated at 2-8C for up to 2 weeks. For long term storage store at -20C in small aliquots to prevent freeze-thaw cycles. |
| Datasheets/Manuals |
Printable datasheet for OAAB17232 |
| Additional Information |
Precautions: SRMS Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. |
| Additional Information |
Function: May be involved in proliferation or differentiation of keratinocytes in the skin (By similarity) |
| Application Info |
WB: 1:1000
IHC-P: 1:50~100 |
| Immunogen |
This SRMS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 19-48 amino acids from the N-terminal region of human SRMS. |
| Uniprot ID |
Q9H3Y6 |
| Protein Name |
Tyrosine-protein kinase Srms |
| Protein Accession # |
NP_543013.1 |
| Gene Symbol |
SRMS |
| Predicted Species Reactivity |
Human |
| Application |
WB, IHC |
| Predicted Homology Based on Immunogen Sequence |
Human |
| Image 1 | HL-60
 | Western blot analysis of anti-SRMS Antibody (N-term) (Cat.# OAAB17232) in HL60 cell line lysates (35ug/lane). SRMS(arrow) was detected using the purified Pab. |
| | Image 2 | breast carcinoma
 | Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma. |
|
|
